ASCEND BY NTHRYS
Research Abroad Products

Immunotechnology Project Topics

Browse all focused areas across all project categories under this field.

Showing 49–60 of 200 project topics
Checkpoint Inhibitor Combination Toxicity Prediction Machine Learning
A machine learning software tool that predicts organ-specific toxicity outcomes when combining checkpoint inhibitors with chemotherapy, targeted drugs, or radiation. Enables pharmaceutical companies to design safer drug combinations, accelerate regulatory submissions, and capture premium pricing for next-generation immunotherapy regimens.
Checkpoint Inhibitor Technology Development Click to view more details →
Immunotherapy Patient Stratification Genomic Database and Analytics
A proprietary genomic database aggregating millions of tumor and immune cell sequencing profiles linked to checkpoint inhibitor treatment outcomes across cancer types. Generates recurring subscription revenue from pharma, biotech, and academic institutions while enabling development of superior patient selection biomarkers for clinical programs.
Checkpoint Inhibitor Technology Development Click to view more details →
NK Cell Manufacturing Automation Platform for GMP Production
An integrated bioreactor and cell processing software platform that automates large-scale NK cell expansion while maintaining FDA/EMA GMP compliance standards. Reduces production costs by 40-60% and accelerates time-to-market for cell therapy manufacturers through standardized, scalable workflows.
Natural Killer Cell Therapy Technology Dev Click to view more details →
Clinical-Grade NK Cell Potency Assay SaaS Analytics
A cloud-based analytical platform that provides real-time NK cell potency, cytotoxicity, and functional characterization testing using proprietary algorithms and machine learning models. Enables contract manufacturers and biotech companies to reduce assay turnaround time by 60% while charging premium pricing for predictive analytics and quality control insights.
Natural Killer Cell Therapy Technology Dev Click to view more details →
NK Cell Cryopreservation Media and Banking Service
A proprietary cryopreservation formulation and cell banking service that maintains NK cell viability and functionality post-thaw at >90% recovery rates. Generates recurring revenue through storage fees, quality assurance testing, and exclusive licensing to clinical trial sponsors and CAR-NK manufacturers.
Natural Killer Cell Therapy Technology Dev Click to view more details →
CAR-NK Cell Vector Design Software Suite
A computational design platform using AI to optimize chimeric antigen receptor constructs specifically for natural killer cells, predicting off-target effects and manufacturing yields. Licenses to pharmaceutical companies and research institutions on a per-project basis, capturing value from faster development cycles and reduced failed engineering iterations.
Natural Killer Cell Therapy Technology Dev Click to view more details →
NK Cell Patient Matching Biomarker Diagnostic Kit
A companion diagnostic tool that identifies patient populations with optimal NK cell receptor profiles, HLA compatibility, and predicted therapeutic response for personalized NK cell therapy selection. Creates a B2B2C revenue model through partnerships with clinical trial sites and hospitals, enabling patient stratification and improving clinical success rates.
Natural Killer Cell Therapy Technology Dev Click to view more details →
Engineered NK Cell Expansion Cytokine Cocktail Product
A specialized growth factor formulation combining optimized concentrations of IL-2, IL-15, IL-21, and proprietary molecules that achieves 500-1000 fold NK cell expansion in 14 days. Provides recurring consumables revenue across contract manufacturers and biopharmaceutical companies scaling NK cell production globally.
Natural Killer Cell Therapy Technology Dev Click to view more details →
NK Cell Immunogenicity Assessment Platform for Allogenic Therapies
A regulatory-grade testing service platform that assesses immunogenicity, HLA typing compatibility, and rejection risk for off-the-shelf allogeneic NK cell products using advanced immune profiling. Positions as a de-risking tool for manufacturers, capturing fees for each product batch tested while reducing clinical trial failure rates.
Natural Killer Cell Therapy Technology Dev Click to view more details →
Real-Time NK Cell Viability and Purity Monitoring Bioreactor Sensor
An inline bioreactor sensor and analytics dashboard that continuously monitors NK cell viability, purity, and metabolic markers throughout manufacturing without sampling bias. Sells as a hardware-software bundle with SaaS subscriptions, generating upfront equipment revenue and recurring analytics licensing fees from GMP manufacturers.
Natural Killer Cell Therapy Technology Dev Click to view more details →
NK Cell Therapy Clinical Trial Management and Safety Tracking Software
A specialized electronic data capture and safety monitoring platform designed for NK cell immunotherapy trials, integrating adverse event reporting, dosing schedules, and real-time efficacy analytics. Captures recurring SaaS revenue from pharmaceutical sponsors and CROs managing multi-site trials, with premium pricing for integrated regulatory submissions.
Natural Killer Cell Therapy Technology Dev Click to view more details →
Off-the-Shelf Universal NK Cell Product Development Service Platform
An end-to-end contract development and manufacturing service combining proprietary NK cell engineering, GMP production, and scalable banking infrastructure for allogeneic ''off-the-shelf'' products. Generates milestone payments, royalties on net sales, and recurring revenue through cryostorage and quality assurance services for pharma partners seeking rapid NK cell commercialization.
Natural Killer Cell Therapy Technology Dev Click to view more details →